Literature DB >> 18921791

Effect of histolyticus infection and toxin on transplantable mouse tumors.

R C PARKER, H C PLUMMER.   

Abstract

Entities:  

Keywords:  BACTERIA/clostridium; TUMORS/experimental

Mesh：

Substances：

Year:  1947        PMID： 18921791     DOI： 10.3181/00379727-66-16124

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  23 in total

1.  Can engineered bacteria help control cancer?

Authors:  R K Jain; N S Forbes
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  [Significance of the immune resistance for the oncolytic effect of clostridia].

Authors:  K Schweizer
Journal:  Naturwissenschaften       Date:  1971-03

3.  Combination bacteriolytic therapy for the treatment of experimental tumors.

Authors:  L H Dang; C Bettegowda; D L Huso; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-27       Impact factor: 11.205

4.  [Tumor therapy with parasites and microorganisms].

Authors:  D Gericke
Journal:  Naturwissenschaften       Date:  1965-12

5.  Motility is critical for effective distribution and accumulation of bacteria in tumor tissue.

Authors:  Bhushan J Toley; Neil S Forbes
Journal:  Integr Biol (Camb)       Date:  2011-12-22       Impact factor: 2.192

Review 6.  Bacteria as vectors for gene therapy of cancer.

Authors:  Chwanrow K Baban; Michelle Cronin; Deirdre O'Hanlon; Gerald C O'Sullivan; Mark Tangney
Journal:  Bioeng Bugs       Date:  2010 Nov-Dec

Review 7.  Bacterial therapies: completing the cancer treatment toolbox.

Authors:  Adam T St Jean; Miaomin Zhang; Neil S Forbes
Journal:  Curr Opin Biotechnol       Date:  2008-09-18       Impact factor: 9.740

Review 8.  Combining anaerobic bacterial oncolysis with vaccination that blocks interleukin-10 signaling may achieve better outcomes for late stage cancer management.

Authors:  Guoying Ni; Tianfang Wang; Lin Yang; Yuejian Wang; Xiaosong Liu; Ming Q Wei
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

Review 9.  Engineering the gut microbiota to treat chronic diseases.

Authors:  Noura S Dosoky; Linda S May-Zhang; Sean S Davies
Journal:  Appl Microbiol Biotechnol       Date:  2020-07-21       Impact factor: 4.813

10.  Tumor-targeted delivery of biologically active TRAIL protein.

Authors:  H-Y Zhang; J-H Man; B Liang; T Zhou; C-H Wang; T Li; H-Y Li; W-H Li; B-F Jin; P-J Zhang; J Zhao; X Pan; K He; W-L Gong; X-M Zhang; A-L Li
Journal:  Cancer Gene Ther       Date:  2010-01-15       Impact factor: 5.987
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.